Dr. Preetha Basaviah, MD

Dr. Basaviah practices at Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University.

Dr. Basaviah's NPI, 1689716003, was assigned on February 13, 2007. Dr. Basaviah graduated from Warren Alpert Medical School of Brown University in 1995. Dr. Basaviah holds California license A72829.

Dr. Basaviah's primary practice is Stanford Hospital at 300 Pasteur Drive, at 300 Pasteur Drive, Stanford, CA 94305 in Santa Clara County. The practice phone is (650) 723-4000.

Dr. Basaviah's primary practice is Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University. The medical group on file is Stanford Health Care. Dmand AI also links Dr. Basaviah to 1 more hospital, named with a free account. Dr. Basaviah's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Basaviah practices, 2 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Basaviah's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Basaviah is licensed in California.

CMS data shows 32 Medicare services from Dr. Basaviah across 2 procedure codes in 2024, all of them office visits, for 34 Medicare patients. Medicare paid $2,027 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 34 Medicare patients who saw Dr. Basaviah in 2024. The largest group is 75 to 84, with 14 patients. 71% of them have high cholesterol, and 68% have high blood pressure. 53% are also on Medicaid. Their average risk score is 1.52, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Basaviah's median patient age at 52, with 50% women.

In 2024, Dr. Basaviah wrote 98 Medicare Part D claims for 20 patients. 85% of them were for generic drugs. CMS names the drug for 19 of them, across 1 drug with 11 or more claims each, at $128 in total drug cost. In 2021, CMS named 11 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Basaviah for performance year 2024, reported as part of a group. Dr. Basaviah accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Basaviah as offering telehealth.

Dmand AI links 11 papers to Dr. Basaviah, published from 2013 to 2024. The most frequent topics are Students, Medical, Clinical Competence and Curriculum. Dr. Basaviah has published most often in Acad Med. Dr. Basaviah's most frequent co-authors are Jason L. Hom, MD, John F. Kugler, MD and John D. Kugler, MD.

CMS Open Payments shows 1 general payment to Dr. Basaviah from 1 drug or device company in 2018. Food and beverage make up the largest share, 100% of the total. GlaxoSmithKline, LLC. paid the most, $23.

Dr. Basaviah graduated from Warren Alpert Medical School of Brown University in 1995.